Business Wire

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership

Share

Crown Bioscience, a JSR Life Sciences company, announced today that it has restructured its commercial leadership team by creating a new Chief Business Officer (CBO) role and with additional investment in commercial talent.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005025/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Effective immediately, Michael Prosser is promoted to Chief Business Officer. Michael has been with Crown Bioscience for over ten years serving in a variety of operational and commercial leadership positions, and most recently served as Senior Vice President, Commercial and Strategic Development. (Photo: Business Wire)

Effective immediately, Michael Prosser is promoted to Chief Business Officer. Michael has been with Crown Bioscience for over ten years serving in a variety of operational and commercial leadership positions, and most recently served as Senior Vice President, Commercial and Strategic Development.

Building on the company’s continued growth, three new roles have been created within the commercial team and will report to Mr. Prosser. Alex Slater, who joined the company last year, has taken on added responsibility for APAC business development as Vice President of Global Business Development; Dr. Jonny McMichael has been appointed to Vice President of Client Experience and Enablement; and Dr. Achim Quandt has joined the company as Executive Director of Product Management.

“Crown Bioscience has grown significantly in recent years, consistently exceeding its annual growth target, and in FY21 we were delighted to record bookings growth of over 40%,” said Armin Spura, CEO. “With these changes announced today and under Michael's continued leadership, we are confident we are putting in place a commercial team that optimally positions Crown Bioscience for our next phase of growth.”

Michael Prosser, CBO, stated: “It’s an honor to be asked to lead the next stage in Crown Bioscience’s commercial growth. Our success to date is directly attributable to our relentless focus on customer experience, product innovation, and setting new industry-leading quality standards, and I’m excited to be working closely with the new team and structure as we strive to continuously improve in all these areas.”

The company added more than four hundred new customers in FY21, and to meet increased customer demand, has accelerated investments in its global footprint, with renovations now complete in APAC laboratories, and notably the formation of a joint venture with sister company MBL in Japan. In Europe and the United States, parallel investments are also planned for site expansions and strategic acquisitions.

###

About Crown Bioscience

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases. The company is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world’s largest commercially available PDX collection. Crown Bioscience helps deliver superior drug candidates to ensure that patients get the right treatment at the right time. Founded in 2006, Crown Bioscience has nine facilities in the US, Europe and Asia. Find out more: https://www.crownbio.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Crown Bioscience
Louise Stenson
pr@crownbio.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Global Alliance on Green Economy launched during World Green Economy Summit in Dubai3.10.2022 09:00:00 CEST | Press release

Under the patronage of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, the 8th World Green Economy Summit (WGES) concluded in Dubai. It was organised by the World Green Economy Organization (WGEO), Dubai Electricity and Water Authority (DEWA), and the Dubai Supreme Council of Energy. The summit was held under the theme ‘Climate Action Leadership through Collaboration: The Roadmap to Net-Zero’. A large number of ministers, experts, decision-makers, officials, representatives of institutions, and the academic community from around the world took part in the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221003005176/en/ Global Alliance on Green Economy launched during World Green Economy Summit in Dubai (Photo: AETOSWire) During a ministerial roundtable on green economy at WGES with around 25 ministers and officials from around the world, HE Saeed Mohammed Al T

Slate Asset Management Holds Third Close of Slate European Essential Real Estate Income Fund3.10.2022 09:00:00 CEST | Press release

Slate Asset Management ("Slate"), a global alternative investment platform targeting real assets, today announced that Slate European Essential Real Estate Income Fund (“SEEREIF” or the “Fund”) has reached its third close of the 2022 calendar year, significantly increasing the Fund’s available equity commitments for deployment. SEEREIF is backed by a diversified group of global institutional investors. The Fund is part of Slate’s core-plus investment strategy focused on European essential real estate, which targets cash yielding assets critical to the supply chain with high credit quality tenants, such as grocery and other essential consumer goods providers, healthcare assets, and affiliated warehouses and logistics centers. Jerry Cain, Managing Director of Investor Relations at Slate, said: “For the second quarter in a row, SEEREIF has closed on capital commitments from Slate’s global institutional partners, indicating that our investors recognize the uniquely resilient nature of this

Monument Re Announces Merger of AME Life Lux S.A. Into Monument Assurance Luxembourg S.A.3.10.2022 09:00:00 CEST | Press release

Monument Re announced today that AME Life Lux S.A. will merge into Monument Assurance Luxembourg S.A. following receipt of regulatory approval from the Commissariat aux Assurances. As a result, Monument Assurance Luxembourg S.A. will be the sole Monument Luxembourg entity following the merger. Monument Re Limited is a reinsurer and asset consolidator with a proven track record in the acquisition and operation of portfolios or direct insurers in Europe. Monument Re has a presence in Bermuda which has full Solvency II equivalence along with Switzerland. The Monument Re Group also operates through its subsidiaries in Belgium, Ireland, Isle of Man, Guernsey and Luxembourg, with branches in Spain, Italy and Germany. Each entity is subject to local regulation and Monument Re is subject to Group Supervision by the Bermuda Monetary Authority. Monument Assurance Luxembourg S.A. is a fully licensed Luxembourg life insurance company regulated by the Commissariat aux Assurances, with branches in S

Prodapt Launches OpenFibreXchange to Accelerate Pan-UK Digital Connectivity3.10.2022 08:00:00 CEST | Press release

Prodapt, a leading global consulting, technology, and managed services provider to the connectedness industry, today announced the launch of its OpenFibreXchange (OFX) that will enable Internet Service Providers (ISPs) to rapidly connect with the regional fibre operators to boost high-speed digital connectivity across the UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220930005312/en/ With a singular focus on the Connectedness industry, Prodapt’s OpenFibreXchange, built on cloud-native, open-source technology, will enable wholesale fibre aggregation in the UK to accelerate digital Connectedness. ISPs can seamlessly connect with regional fibre operators via OFX to deliver pan-UK digital connectivity. Prodapt is committed to accelerating the digitisation of Britain and connecting hard-to-reach communities. The investment in OFX resulted from open discussions with delegates from retail & wholesale fibre AltNets, incumbent o

Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation3.10.2022 08:00:00 CEST | Press release

Treatment of cancer using one’s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, radiotherapy and surgery, practiced in Japan for long is now offered in Vinmec hospital, Hanoi, Vietnam, following technology transfer by GN Corporation. Cancer patients from neighboring countries are now visiting Vinmec hospital for this treatment. Autologous immune-cell therapy, regulated by the regenerative medicine law in Japan, uses lab-expanded autologous immune cells, without animal proteins or genetic manipulation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221002005087/en/ NK cells and T-cells in vitro culture method, without feeder cells or animal serum or genetic manipulation, for immune-cell therapy to cancer patients developed and practiced in Japan was tech-transferred to Vinmec Hospital, Hanoi, Vietnam, which was